RecruitingNCT06805071
Decisional Regret in Open Partial Horizontal Laryngectomy
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Enrollment
100 participants
Start Date
May 1, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
Prospective multicentric study to evaluate decisional regret and psychometric and functional outcomes in patient previously treated with Open Horizontal partial Laryngectomy
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study is exploring how often patients who underwent a specific type of partial voice box (larynx) surgery for throat cancer experience regret about their treatment decision, and what factors contribute to that regret.
**You may be eligible if...**
- You had squamous cell carcinoma (a type of throat cancer) treated with open partial horizontal laryngectomy — a surgery that removes part of the voice box while preserving some speaking and swallowing function
**You may NOT be eligible if...**
- You had prior surgery on your larynx (voice box) before this procedure
- You previously received radiation or chemoradiation to the head and neck area
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06805071
Related Trials
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
NCT06532279149 locations
Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation
NCT066620581 location
Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
NCT069800385 locations
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
NCT02734537640 locations
Personalized Elective Neck Irradiation Guided by Sentinel Lymph Node Biopsy in Larynx and Pharynx Cancer. The PRIMO Study.
NCT053335239 locations